🇺🇸 FDA
Pipeline program

TV-45070

TV-45070-CNS-20005

Phase 2 small_molecule completed

Quick answer

TV-45070 for Osteoarthritis of the Knee is a Phase 2 program (small_molecule) at Teva Pharma GmbH with 1 ClinicalTrials.gov record(s).

Program details

Company
Teva Pharma GmbH
Indication
Osteoarthritis of the Knee
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials